Cue Biopharma, Inc. (CUE)
NASDAQ · Manufacturing · Pharmaceutical preparations
CUE price, last 12 months
Key stats
- Previous close
- $4.76
- Open
- $4.48
- Day range
- $3.85 – $5.16
- 52-week range
- $2.83 – $45.50
- Volume
- 2.1M
- Avg volume (20 days)
- 1.1M
- Market cap
- $117.1M
Performance
Technicals and fundamentals
About Cue Biopharma, Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $117.1M